Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

Published:2013-11-10 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Nannini Luis Javier¹,Poole Phillippa²,Milan Stephen J³,Holmes Rebecca⁴,Normansell Rebecca⁵

Affiliation:

1. Hospital E Peron; Pulmonary Section; Ruta 11 Y Jm Estrada G. Baigorria Santa Fe - Rosario Argentina 2152

2. University of Auckland; Department of Medicine; Private Bag 92019 Auckland New Zealand

3. Lancaster University; Medical School; Lancaster UK

4. St George's, University of London; Population Health Sciences and Education; London UK

5. St George's, University of London; Cochrane Airways, Population Health Research Institute; London UK SW17 0RE

Publisher

Wiley

Subject

Pharmacology (medical)

Reference254 articles.

1. Barnes NC Qiu Y Pavord I Parker D Johnson M Thompson M Salmeterol/fluticasone propionate (SFC) anti-inflammatory effects in COPD [Abstract]. American Thoracic Society 2005 International Conference; May 20-25; San Diego 2005 B93 [Poster 320]

2. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease;Barnes;American Journal of Respiratory & Critical Care Medicine,2006

3. Qiu Y Parker D Barnes NC Johnson M Pavord L The effect of salmeterol/fluticasone propionate (SFC) on eosinophils and mast cells in COPD [Abstract]. American Thoracic Society 2005 International Conference; May 20-25; San Diego 2005 A43 [Poster F36]

4. Anti-inflammatory effects of salmeterol/fluticasone propionate (SFC) on airway T-lymphocyte populations in COPD;Qiu;European Respiratory Journal,2005

5. Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in COPD: a placebo-controlled study of endobronchial biopsies;Qiu;European Respiratory Journal,2005

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled corticosteroids and risk of lower respiratory tract infection withMoraxella catarrhalisin patients with chronic obstructive pulmonary disease;BMJ Open Respiratory Research;2023-08

2. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2023-06-05

3. Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population;ERJ Open Research;2021-12-10

4. Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study;International Journal of Chronic Obstructive Pulmonary Disease;2021-11

5. Case-finding and improving patient outcomes for chronic obstructive pulmonary disease in primary care: the BLISS research programme including cluster RCT;Programme Grants for Applied Research;2021-11